✦ LIBER ✦

Expression profiles of Fas/Fas ligand and tumor suppressor genes in human granulosa cells.

✍ Scribed by C Keck; D Pietrowski

Book ID: 119417785
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 21 KB
Volume: 76
Category: Article
ISSN: 1556-5653
DOI: 10.1016/s0015-0282(01)02479-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Co-expression of Fas and Fas ligand in h

Co-expression of Fas and Fas ligand in human non-astrocytic glial tumors

✍ B. Frankel; Sharon L. Longo; Timothy C. Ryken 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 172 KB

Expression of Fas and Fas ligand in huma

Expression of Fas and Fas ligand in human testicular germ cell tumours

✍ E. Baldini; S. Ulisse; E. Marchioni; A. Di Benedetto; G. Giovannetti; E. Petrang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Tamoxifen induces apoptosis in Fas+tumor

Tamoxifen induces apoptosis in Fas+tumor cells by upregulating the expression of Fas ligand

✍ Nisha Nagarkatti; Barbara A. Davis 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 371 KB

Co-expression of Fas and Fas ligand in m

Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines

✍ Nuzhat Husain; E. A. Chiocca; Nikolai Rainov; David N. Louis; Nicholas T. Zervas 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 216 KB

Fas and Fas ligand expression in tumor c

Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas

✍ Lucie Peduto Eberl; Louis Guillou; Emilia Saraga; Michael Schröter; Lars E. Fren 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 906 KB

CD95/APO-1 ligand (FasL) is implicated in the maintenance of immune privileged sites by inducing apoptosis of activated infiltrating T lymphocytes. Therefore, progressive tumors might express high levels of FasL and develop as immune privileged sites. In this study, we investigated the expression of

Expression of Fas and Fas ligand in cuta

Expression of Fas and Fas ligand in cutaneous B-cell lymphomas

✍ Zoi-Toli, Ourania; Meijer, Chris J. L. M.; Oudejans, Joost J.; de Vries, Els; va 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 3 views

Primary cutaneous B-cell lymphomas (CBCLs) represent a rare, but distinct group of B-cell neoplasms with a different clinical behaviour to B-cell lymphomas secondarily involving the skin. Fas-Fas ligand (Fasl) expression was investigated in a group of primary and secondary CBCLs to gain an insight i